Skip to main content

and
  1. No Access

    Article

    Integrating molecular diagnostics into anticancer drug discovery

    Efforts to repeat the success of pioneering molecularly targeted cancer drugs, such as trastuzumab, for particular patient populations have been hampered by factors such as a lack of correlation between the mo...

    István Peták, Richárd Schwab, László Őrfi, László Kopper in Nature Reviews Drug Discovery (2010)

  2. Article

    Open Access

    TT-232: An Anti-tumour and Anti-inflammatory Peptide Therapeutic in Clinical Development

    TT-232 is a structural derivative of the peptide hormone somatostatin with selective anti-proliferative and anti-inflammatory properties. It has a strong anti-tumour activity both in vitro and in vivo on a wide r...

    György Kéri, Richard Schwab in International Journal of Peptide Research … (2005)